UniProt ID | NVL_HUMAN | |
---|---|---|
UniProt AC | O15381 | |
Protein Name | Nuclear valosin-containing protein-like | |
Gene Name | NVL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 856 | |
Subcellular Localization |
Isoform 2: Nucleus, nucleoplasm . Isoform 1: Nucleus, nucleolus . Nucleus, nucleoplasm . Expressed predominantly in the nucleolus. Associates with pre-ribosomal particles in the nucleus. |
|
Protein Description | Participates in the assembly of the telomerase holoenzyme and effecting of telomerase activity via its interaction with TERT. [PubMed: 22226966 May play a role in 60S ribosomal subunit biogenesis] | |
Protein Sequence | MKPRPAGFVDNKLKQRVIQYLTSNKCGKYVDIGVLASDLQRVYSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTELEDEHLAKRARQGEEDNEYTESYSDDDSSMEDYPDPQSANHMNSSLLSLYRKGNPDSVSNTPEMEQRETTSSTPRISSKTGSIPLKTPAKDSEGGWFIDKTPSVKKDSFFLDLSCEKSNPKKPITEIQDSKDSSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKAKARGLEFQISNVKFEDVGGNDMTLKEVCKMLIHMRHPEVYHHLGVVPPRGVLLHGPPGCGKTLLAHAIAGELDLPILKVAAPEIVSGVSGESEQKLRELFEQAVSNAPCIIFIDEIDAITPKREVASKDMERRIVAQLLTCMDDLNNVAATARVLVIGATNRPDSLDPALRRAGRFDREICLGIPDEASRERILQTLCRKLRLPQAFDFCHLAHLTPGFVGADLMALCREAAMCAVNRVLMKLQEQQKKNPEMEDLPSKGVQEERLGTEPTSETQDELQRLLGLLRDQDPLSEEQMQGLCIELNDFIVALSSVQPSAKREGFVTVPNVTWADIGALEDIREELTMAILAPVRNPDQFKALGLVTPAGVLLAGPPGCGKTLLAKAVANESGLNFISVKGPELLNMYVGESERAVRQVFQRAKNSAPCVIFFDEVDALCPRRSDRETGASVRVVNQLLTEMDGLEARQQVFIMAATNRPDIIDPAILRPGRLDKTLFVGLPPPADRLAILKTITKNGTKPPLDADVNLEAIAGDLRCDCYTGADLSALVREASICALRQEMARQKSGNEKGELKVSHKHFEEAFKKVRSSISKKDQIMYERLQESLSR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Sulfoxidation | -------MKPRPAGF -------CCCCCCCC | 14.05 | 31801345 | |
12 | Ubiquitination | PAGFVDNKLKQRVIQ CCCCCCHHHHHHHHH | 53.23 | - | |
15 (in isoform 2) | Phosphorylation | - | 56.14 | - | |
20 | Phosphorylation | LKQRVIQYLTSNKCG HHHHHHHHHHCCCCC | 10.79 | 20068231 | |
22 | Phosphorylation | QRVIQYLTSNKCGKY HHHHHHHHCCCCCCE | 25.89 | 20068231 | |
23 | Phosphorylation | RVIQYLTSNKCGKYV HHHHHHHCCCCCCEE | 31.53 | 20068231 | |
25 | Ubiquitination | IQYLTSNKCGKYVDI HHHHHCCCCCCEEEE | 44.10 | - | |
28 | Acetylation | LTSNKCGKYVDIGVL HHCCCCCCEEEEEEH | 52.12 | 26051181 | |
28 (in isoform 2) | Phosphorylation | - | 52.12 | - | |
29 | Phosphorylation | TSNKCGKYVDIGVLA HCCCCCCEEEEEEHH | 6.66 | 22817900 | |
32 (in isoform 2) | Phosphorylation | - | 2.68 | - | |
37 | Phosphorylation | VDIGVLASDLQRVYS EEEEEHHHHHHHHHH | 34.39 | 24719451 | |
43 | Phosphorylation | ASDLQRVYSIDYGRR HHHHHHHHHCCCCCC | 11.33 | 22817900 | |
44 | Phosphorylation | SDLQRVYSIDYGRRK HHHHHHHHCCCCCCC | 13.21 | 21815630 | |
47 | Phosphorylation | QRVYSIDYGRRKRNA HHHHHCCCCCCCCCE | 15.74 | 22817900 | |
53 (in isoform 2) | Phosphorylation | - | 46.60 | - | |
64 | Phosphorylation | IQVEKVFSIISSEKE HHHHHHHHHHCCHHH | 23.23 | 29523821 | |
67 | Phosphorylation | EKVFSIISSEKELKN HHHHHHHCCHHHHCC | 30.67 | 24505115 | |
68 | Phosphorylation | KVFSIISSEKELKNL HHHHHHCCHHHHCCC | 42.13 | 29523821 | |
70 | Acetylation | FSIISSEKELKNLTE HHHHCCHHHHCCCHH | 71.00 | 23749302 | |
70 | Ubiquitination | FSIISSEKELKNLTE HHHHCCHHHHCCCHH | 71.00 | - | |
73 | Ubiquitination | ISSEKELKNLTELED HCCHHHHCCCHHHCH | 51.51 | - | |
76 | Phosphorylation | EKELKNLTELEDEHL HHHHCCCHHHCHHHH | 48.17 | 28555341 | |
79 (in isoform 2) | Phosphorylation | - | 55.94 | - | |
85 | Acetylation | LEDEHLAKRARQGEE HCHHHHHHHHHCCCC | 53.61 | 25953088 | |
85 | Ubiquitination | LEDEHLAKRARQGEE HCHHHHHHHHHCCCC | 53.61 | - | |
85 (in isoform 2) | Phosphorylation | - | 53.61 | - | |
89 (in isoform 2) | Phosphorylation | - | 63.77 | - | |
101 | Phosphorylation | NEYTESYSDDDSSME CCCCCCCCCCCCCCC | 43.79 | 19691289 | |
101 (in isoform 2) | Phosphorylation | - | 43.79 | - | |
104 (in isoform 2) | Phosphorylation | - | 47.83 | - | |
105 | Phosphorylation | ESYSDDDSSMEDYPD CCCCCCCCCCCCCCC | 38.28 | 19691289 | |
105 (in isoform 2) | Phosphorylation | - | 38.28 | - | |
109 (in isoform 2) | Phosphorylation | - | 52.18 | - | |
110 | Phosphorylation | DDSSMEDYPDPQSAN CCCCCCCCCCHHHHC | 9.02 | 26307563 | |
115 | Phosphorylation | EDYPDPQSANHMNSS CCCCCHHHHCCCCHH | 36.10 | 26307563 | |
121 | Phosphorylation | QSANHMNSSLLSLYR HHHCCCCHHHHHHHH | 18.13 | 20068231 | |
122 | Phosphorylation | SANHMNSSLLSLYRK HHCCCCHHHHHHHHH | 28.46 | 26307563 | |
125 | Phosphorylation | HMNSSLLSLYRKGNP CCCHHHHHHHHHCCC | 28.75 | 26307563 | |
127 | Phosphorylation | NSSLLSLYRKGNPDS CHHHHHHHHHCCCCC | 13.60 | 26307563 | |
129 | Acetylation | SLLSLYRKGNPDSVS HHHHHHHHCCCCCCC | 49.86 | 19815419 | |
129 | Ubiquitination | SLLSLYRKGNPDSVS HHHHHHHHCCCCCCC | 49.86 | - | |
134 | Phosphorylation | YRKGNPDSVSNTPEM HHHCCCCCCCCCCHH | 28.80 | 25159151 | |
136 | Phosphorylation | KGNPDSVSNTPEMEQ HCCCCCCCCCCHHHH | 38.65 | 21712546 | |
138 | Phosphorylation | NPDSVSNTPEMEQRE CCCCCCCCCHHHHHH | 17.08 | 25159151 | |
141 | Sulfoxidation | SVSNTPEMEQRETTS CCCCCCHHHHHHCCC | 5.83 | 21406390 | |
147 | Phosphorylation | EMEQRETTSSTPRIS HHHHHHCCCCCCCCC | 18.87 | - | |
149 | Phosphorylation | EQRETTSSTPRISSK HHHHCCCCCCCCCCC | 40.10 | 25159151 | |
150 | Phosphorylation | QRETTSSTPRISSKT HHHCCCCCCCCCCCC | 19.16 | 25159151 | |
156 | Acetylation | STPRISSKTGSIPLK CCCCCCCCCCCCCCC | 50.55 | 25953088 | |
156 | Ubiquitination | STPRISSKTGSIPLK CCCCCCCCCCCCCCC | 50.55 | - | |
157 | Phosphorylation | TPRISSKTGSIPLKT CCCCCCCCCCCCCCC | 37.80 | 29396449 | |
159 | Phosphorylation | RISSKTGSIPLKTPA CCCCCCCCCCCCCCC | 26.68 | 21815630 | |
163 | Ubiquitination | KTGSIPLKTPAKDSE CCCCCCCCCCCCCCC | 47.29 | - | |
164 | Phosphorylation | TGSIPLKTPAKDSEG CCCCCCCCCCCCCCC | 35.84 | 25159151 | |
167 | Acetylation | IPLKTPAKDSEGGWF CCCCCCCCCCCCCEE | 64.09 | 26051181 | |
167 | Ubiquitination | IPLKTPAKDSEGGWF CCCCCCCCCCCCCEE | 64.09 | - | |
177 | Acetylation | EGGWFIDKTPSVKKD CCCEEECCCCCCCCC | 58.48 | 26051181 | |
177 | Ubiquitination | EGGWFIDKTPSVKKD CCCEEECCCCCCCCC | 58.48 | - | |
178 | Phosphorylation | GGWFIDKTPSVKKDS CCEEECCCCCCCCCC | 19.63 | 25159151 | |
180 | Phosphorylation | WFIDKTPSVKKDSFF EEECCCCCCCCCCEE | 52.37 | 25159151 | |
185 | Phosphorylation | TPSVKKDSFFLDLSC CCCCCCCCEEEEEEC | 27.12 | 25159151 | |
191 | Phosphorylation | DSFFLDLSCEKSNPK CCEEEEEECCCCCCC | 21.64 | 25159151 | |
192 | Glutathionylation | SFFLDLSCEKSNPKK CEEEEEECCCCCCCC | 11.25 | 22555962 | |
194 | Ubiquitination | FLDLSCEKSNPKKPI EEEEECCCCCCCCCC | 60.92 | - | |
195 | Phosphorylation | LDLSCEKSNPKKPIT EEEECCCCCCCCCCC | 35.75 | 20068231 | |
199 | Ubiquitination | CEKSNPKKPITEIQD CCCCCCCCCCCCCCC | 42.80 | - | |
202 | Phosphorylation | SNPKKPITEIQDSKD CCCCCCCCCCCCCCC | 35.25 | 30108239 | |
207 | Phosphorylation | PITEIQDSKDSSLLE CCCCCCCCCCCCHHH | 23.22 | 25159151 | |
208 | Sumoylation | ITEIQDSKDSSLLES CCCCCCCCCCCHHHH | 70.67 | - | |
208 | Sumoylation | ITEIQDSKDSSLLES CCCCCCCCCCCHHHH | 70.67 | 28112733 | |
210 | Phosphorylation | EIQDSKDSSLLESDM CCCCCCCCCHHHHHH | 26.99 | 25159151 | |
211 | Phosphorylation | IQDSKDSSLLESDMK CCCCCCCCHHHHHHH | 47.29 | 25159151 | |
215 | Phosphorylation | KDSSLLESDMKRKGK CCCCHHHHHHHHHCC | 42.87 | 26166824 | |
249 (in isoform 2) | Phosphorylation | - | 42.00 | - | |
275 | Acetylation | GGNDMTLKEVCKMLI CCCCCCHHHHHHHHH | 38.65 | 26051181 | |
290 | Phosphorylation | HMRHPEVYHHLGVVP HHCCHHHHHCCCCCC | 5.05 | - | |
336 | Phosphorylation | VAAPEIVSGVSGESE HCCCHHHHCCCCCCH | 38.86 | 20860994 | |
345 | Ubiquitination | VSGESEQKLRELFEQ CCCCCHHHHHHHHHH | 45.52 | - | |
355 | Phosphorylation | ELFEQAVSNAPCIIF HHHHHHHHCCCEEEE | 30.23 | 20058876 | |
370 | Phosphorylation | IDEIDAITPKREVAS EEECCCCCCCHHHCC | 25.20 | 24719451 | |
410 | Phosphorylation | RVLVIGATNRPDSLD EEEEEECCCCCCCCC | 26.92 | 20068231 | |
492 | Ubiquitination | AVNRVLMKLQEQQKK HHHHHHHHHHHHHHH | 42.74 | - | |
498 | Acetylation | MKLQEQQKKNPEMED HHHHHHHHHCCCHHH | 54.96 | 22361351 | |
499 | Ubiquitination | KLQEQQKKNPEMEDL HHHHHHHHCCCHHHC | 73.69 | - | |
508 | Phosphorylation | PEMEDLPSKGVQEER CCHHHCCCCCCCHHH | 49.71 | 24719451 | |
509 | Acetylation | EMEDLPSKGVQEERL CHHHCCCCCCCHHHH | 62.25 | 26051181 | |
509 | Ubiquitination | EMEDLPSKGVQEERL CHHHCCCCCCCHHHH | 62.25 | - | |
562 (in isoform 3) | Ubiquitination | - | 26.14 | 21890473 | |
570 | Ubiquitination | VQPSAKREGFVTVPN CCCCCCCCCCEECCC | 57.17 | 21890473 | |
626 | Glutathionylation | LLAGPPGCGKTLLAK EEECCCCCCHHHHHH | 6.61 | 22555962 | |
628 | Acetylation | AGPPGCGKTLLAKAV ECCCCCCHHHHHHHH | 39.82 | 26051181 | |
629 | Phosphorylation | GPPGCGKTLLAKAVA CCCCCCHHHHHHHHH | 16.58 | 22817900 | |
633 | Ubiquitination | CGKTLLAKAVANESG CCHHHHHHHHHCCCC | 43.28 | - | |
653 (in isoform 2) | Ubiquitination | - | 32.15 | 21890473 | |
655 | Phosphorylation | GPELLNMYVGESERA CHHHHHHHHCCHHHH | 12.29 | 20068231 | |
668 | Ubiquitination | RAVRQVFQRAKNSAP HHHHHHHHHHHHCCC | 45.63 | 21890473 | |
671 | Ubiquitination | RQVFQRAKNSAPCVI HHHHHHHHHCCCEEE | 54.33 | - | |
695 (in isoform 2) | Phosphorylation | - | 38.65 | - | |
759 | Ubiquitination | ADRLAILKTITKNGT HHHHHHHHHHHCCCC | 31.59 | 21890473 | |
759 (in isoform 1) | Ubiquitination | - | 31.59 | 21890473 | |
794 | Phosphorylation | CYTGADLSALVREAS CCCCCCHHHHHHHHH | 21.80 | 20068231 | |
801 | Phosphorylation | SALVREASICALRQE HHHHHHHHHHHHHHH | 17.28 | 20068231 | |
814 | Phosphorylation | QEMARQKSGNEKGEL HHHHHHHCCCCCCCC | 38.21 | 21406692 | |
826 | Ubiquitination | GELKVSHKHFEEAFK CCCCCCHHHHHHHHH | 42.35 | - | |
833 | Acetylation | KHFEEAFKKVRSSIS HHHHHHHHHHHHHCC | 58.36 | 26051181 | |
837 | Phosphorylation | EAFKKVRSSISKKDQ HHHHHHHHHCCHHHH | 34.70 | 26699800 | |
838 | Phosphorylation | AFKKVRSSISKKDQI HHHHHHHHCCHHHHH | 21.95 | 26699800 | |
840 | Phosphorylation | KKVRSSISKKDQIMY HHHHHHCCHHHHHHH | 35.28 | 21406692 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NVL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NVL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NVL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DPYL1_HUMAN | CRMP1 | physical | 16169070 | |
UBC9_HUMAN | UBE2I | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; THR-138; SER-185AND SER-191, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; THR-138; SER-159;SER-207 AND SER-211, AND MASS SPECTROMETRY. |